Health In Tech, Inc. (HIT) Q2 2026 Earnings Call Transcript
Health In Tech, Inc. (HIT) Q2 2026 Earnings Call Transcript
Seeking Alpha8/14/2026Neutral
HIT
Health In Tech, Inc. Class A Common StockNASDAQTECHNOLOGYSOFTWARE - APPLICATION
Key Statistics
Market Cap
$66.19M
P/E Ratio
—
EPS
$-0.07
Beta
—
52W High
$4.02
52W Low
$0.85
50-Day MA
$1.06
200-Day MA
$1.39
Dividend Yield
—
Profit Margin
-12.00%
Forward P/E
136.99
PEG Ratio
—
About Health In Tech, Inc. Class A Common Stock
Health In Tech, Inc. (HIT) is a leading innovator in the digital health sector, dedicated to enhancing healthcare delivery through advanced technology solutions. The company leverages state-of-the-art data analytics and proprietary software to empower healthcare providers and patients alike, facilitating informed decision-making and improved operational efficiencies. With a strong commitment to compliance and cybersecurity, HIT is adept at addressing the challenges of the rapidly evolving digital health environment. As the industry continues to grow, HIT is strategically positioned to capitalize on emerging opportunities, playing a pivotal role in the global advancement of technology-driven healthcare solutions.
Fundamentals
| Revenue (TTM) | $32.83M |
| Gross Profit (TTM) | $17.70M |
| EBITDA | $2.43M |
| Operating Margin | -42.70% |
| Return on Equity | -21.90% |
| Return on Assets | -12.70% |
| Revenue/Share (TTM) | $0.56 |
| Book Value | $0.30 |
| Price-to-Book | 3.37 |
| Price-to-Sales (TTM) | 2.02 |
| EV/Revenue | 1.811 |
| EV/EBITDA | 291.33 |
| Quarterly Earnings Growth (YoY) | 10.30% |
| Quarterly Revenue Growth (YoY) | -13.50% |
| Shares Outstanding | $53.84M |
| Float | $20.23M |
| % Insiders | 61.96% |
| % Institutions | 8.78% |
Historical Volatility
HV 10-Day
51.35%
HV 20-Day
53.93%
HV 30-Day
53.77%
HV 60-Day
63.20%
HV Rank
0.4%
Volatility is currently contracting
Analyst Ratings
Consensus ($3.70 target)
1
Strong Buy1
BuyLatest News
Health In Tech Q2 Earnings Call Highlights
Health In Tech NASDAQ: HIT reported second-quarter revenue of $8.1 million, down 13.5% from $9.3 million in the year-earlier period, as the company said the onboarding of a new carrier shifted certain policy effective dates into later quarters.
MarketBeat8/14/2026Positive
Health In Tech Reports Second Quarter 2026 Financial Results
Contracted Revenue of $32.3 Million as of June 30, 2026 Pipeline Revenue of $66.3 Million as of July 31, 2026 Distribution Partners Grew 19.9% Year Over Year STUART, Fla., Aug. 13, 2026 /PRNewswire/ -- Health In Tech, Inc. (Nasdaq: HIT) ("Health In Tech" or the "Company"), an AI-enabled InsurTech platform company, today announced its unaudited financial results for the three and six months ended June 30, 2026.
PRNewsWire8/13/2026Neutral
Health In Tech to Announce Second Quarter 2026 Financial Results on August 13, 2026
STUART, Fla., Aug. 3, 2026 /PRNewswire/ -- Health In Tech, Inc. (Nasdaq: HIT), an AI-enabled InsurTech platform company, today announced that it will release financial results for the second quarter ended June 30, 2026, following the close of market on Wednesday, August 13, 2026.
PRNewsWire8/3/2026Neutral
Health In Tech Added to Membership of Russell Microcap® Index
STUART, Fla., June 29, 2026 /PRNewswire/ -- Health In Tech, Inc. (Nasdaq: HIT) ("Health In Tech" or the "Company") was added as a member of the Russell Microcap® Index, effective when the U.S. market opens on June 29, 2026, as part of the 2026 Russell U.S. indexes reconstitution.
PRNewsWire6/29/2026Neutral
Health In Tech, Inc. (HIT) Q1 2026 Earnings Call Transcript
Health In Tech, Inc. (HIT) Q1 2026 Earnings Call Transcript
Seeking Alpha5/14/2026Neutral
Health In Tech Reports First Quarter 2026 Financial Results
Reiterates Guidance for 2026 Annual Revenue Ranging between $45 Million and $50 Million STUART, Fla., May 13, 2026 /PRNewswire/ -- Health In Tech, Inc. (Nasdaq: HIT) ("Health In Tech" or "Company"), an AI-enabled InsurTech platform company, today announced its unaudited financial results for the three months ended March 31, 2026.
PRNewsWire5/13/2026Neutral
Health In Tech to Announce First Quarter 2026 Financial Results on May 13, 2026
STUART, Fla., April 30, 2026 /PRNewswire/ -- Health In Tech, Inc. (Nasdaq: HIT), an AI-enabled InsurTech platform company, today announced that it will release financial results for the first quarter ended March 31, 2026, following the close of market on Wednesday, May 13, 2026.
PRNewsWire4/30/2026Neutral
Cadrenal Therapeutics Announces End-of-Phase 2 Meeting with the FDA and Pivotal Phase 3 Registration Path for CAD-1005 in Heparin-Induced Thrombocytopenia (HIT)
FDA provided critical guidance for the advancement of CAD-1005 to pivotal Phase 3 in HIT Phase 2 data showed a greater than 25% absolute reduction in thrombotic events when CAD-1005 was added to standard anticoagulant therapy PONTE VEDRA, Fla., April 30, 2026 (GLOBE NEWSWIRE) -- Cadrenal Therapeutics, Inc. (Nasdaq: CVKD), a biopharmaceutical company developing innovative treatments for life-threatening immune and thrombotic conditions, today announced a major regulatory milestone after successfully completing its End-of-Phase 2 (EOP2) meeting with the U.S. Food and Drug Administration (FDA) and receiving guidance on key elements of the Phase 3 pivotal trial for CAD-1005, the Company's investigational first-in-class 12-lipoxygenase (12-LOX) inhibitor for heparin-induced thrombocytopenia (HIT).
GlobeNewsWire4/30/2026Neutral
Health In Tech to Present at the Market Movers Investor Summit
STUART, Fla., April 21, 2026 /PRNewswire/ -- Health In Tech, Inc. (Nasdaq: HIT) (the "Company"), an AI-enabled InsurTech platform company, today announced that it will be participating in the Market Movers Investor Summit on Tuesday, May 5, 2026.
PRNewsWire4/21/2026Neutral
Turn research into an automated options-selling system
Tiblio connects your broker and runs your put-and-call-writing strategy for you — on HIT and any ticker you trade — then tracks every position and per-strategy win rate.
More TECHNOLOGY Stocks
Data last updated: 8/18/2026